Silverback Therapeutics (SBTX) News Today $16.95 -0.14 (-0.82%) As of 07/8/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock SBTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Silverback Therapeutics (NASDAQ:SBTX) Trading Up 4.9% - Here's WhyJune 25, 2025 | marketbeat.comSilverback Therapeutics (NASDAQ:SBTX) Stock Price Down 6.8% - Here's WhyJune 3, 2025 | marketbeat.comSilverback Therapeutics (NASDAQ:SBTX) Stock Price Down 3.8% - Here's WhyMay 12, 2025 | marketbeat.comSilverback Therapeutics (NASDAQ:SBTX) Shares Down 0.7% - Here's WhyApril 20, 2025 | marketbeat.comSilverback Therapeutics (NASDAQ:SBTX) Stock Price Up 2% - Here's WhyMarch 27, 2025 | marketbeat.comSilverback Therapeutics (NASDAQ:SBTX) Shares Down 2.9% - Here's What HappenedMarch 5, 2025 | marketbeat.comSilverback Therapeutics (NASDAQ:SBTX) Stock Price Down 6.9% - Here's WhyFebruary 11, 2025 | marketbeat.comSilverback Therapeutics (NASDAQ:SBTX) Trading Down 2%April 3, 2024 | marketbeat.comRoyce & Associates LP Invests $1.98 Million in Silverback Therapeutics, Inc. (NASDAQ:SBTX)September 13, 2023 | marketbeat.comSR One Capital Management LP Purchases 1,003,226 Shares of Silverback Therapeutics, Inc. (NASDAQ:SBTX)August 11, 2023 | marketbeat.comLevin Capital Strategies L.P. Boosts Stake in Silverback Therapeutics, Inc. (NASDAQ:SBTX)July 7, 2023 | marketbeat.comVontobel Holding Ltd. Raises Holdings in Silverback Therapeutics, Inc. (NASDAQ:SBTX)June 29, 2023 | marketbeat.comCitigroup Inc. Boosts Stock Holdings in Silverback Therapeutics, Inc. (NASDAQ:SBTX)June 2, 2023 | marketbeat.comSilverback Therapeutics, Inc. (NASDAQ:SBTX) Shares Sold by K2 Principal Fund L.P.May 26, 2023 | marketbeat.comARS Pharmaceuticals Inc (SPRY)May 11, 2023 | uk.investing.comErgoteles LLC Has $394,000 Stock Position in Silverback Therapeutics, Inc. (NASDAQ:SBTX)March 3, 2023 | marketbeat.comRubric Capital Management LP Has $14.23 Million Stock Position in Silverback Therapeutics, Inc. (NASDAQ:SBTX)February 17, 2023 | marketbeat.comSPRY ARS Pharmaceuticals, Inc.January 24, 2023 | seekingalpha.comARS Pharma CEO Richard Lowenthal Holds 8% Silverback Stake After MergerNovember 22, 2022 | 247wallst.comDr. Sarina Tanimoto Discloses Position in SBTX / Silverback TherapeuticsNovember 18, 2022 | nasdaq.comARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including AnaphylaxisNovember 10, 2022 | finance.yahoo.comARS Pharmaceuticals Closes Merger with Silverback TherapeuticsNovember 8, 2022 | finance.yahoo.comSilverback : FDA Accepts ARS Pharm's NDA For Neffy For Treatment Of Allergic ReactionsOctober 28, 2022 | markets.businessinsider.comSilverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including AnaphylaxisOctober 21, 2022 | finance.yahoo.comSilverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Up 83.5% in SeptemberOctober 14, 2022 | marketbeat.comINVESTIGATION ALERT: Halper Sadeh LLC Investigates CVET, SBTX, IRBTSeptember 17, 2022 | markets.businessinsider.comSBTX Silverback Therapeutics, Inc.September 15, 2022 | seekingalpha.comSHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBTSeptember 6, 2022 | markets.businessinsider.comSHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZYAugust 23, 2022 | markets.businessinsider.comSHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, HNGR, SBTXAugust 17, 2022 | apnews.comASHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates IEA, BBQ, SBTXAugust 11, 2022 | apnews.comASilverback Therapeutics, Inc. (NASDAQ:SBTX) Sees Significant Decrease in Short InterestJuly 31, 2022 | marketbeat.comSHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing InvestigationsJuly 30, 2022 | morningstar.comMINVESTIGATION ALERT: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZYJuly 28, 2022 | apnews.comAShareholder Alert - The M&A Class Action Firm Announces the Investigation of Silverback Therapeutics, Inc. - SBTXJuly 27, 2022 | benzinga.comLifshitz Law PLLC Announces Investigation of IEA, ZY, SBTX, and HNGRJuly 26, 2022 | apnews.comASilverback Therapeutics plans merger with San Diego biotechJuly 26, 2022 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HNGR, SBTX, UJuly 25, 2022 | apnews.comASILVERBACK THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of SBTX and Encourages Investors to Contact the FirmJuly 22, 2022 | benzinga.comSHAREHOLDER ALERT: Weiss Law Investigates Silverback Therapeutics, Inc.July 22, 2022 | prnewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HNGR, ONEM, SBTX, ZENJuly 22, 2022 | apnews.comAOnce A Cancer Company, Silverback Merges With Small Biotech Working On Allergy TreatmentJuly 22, 2022 | finance.yahoo.comSilverback Therapeutics Shares Down After Merger NewsJuly 22, 2022 | marketwatch.comSilverback Therapeutics to merge with San Diego biotech company developing EpiPen alternativeJuly 22, 2022 | msn.comSBTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Silverback Therapeutics, Inc. Is Fair to ShareholdersJuly 21, 2022 | benzinga.comSilverback Therapeutics and ARS Pharmaceuticals Announce MergerJuly 21, 2022 | finance.yahoo.comSilverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Down 32.4% in JuneJuly 17, 2022 | marketbeat.comWhat You Need To Know About Silverback Therapeutics, Inc.'s (NASDAQ:SBTX) Investor CompositionJune 22, 2022 | finance.yahoo.comSilverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Down 16.5% in MayJune 17, 2022 | marketbeat.comSilverback Therapeutics (NASDAQ:SBTX) Stock Rating Lowered by Zacks Investment ResearchJune 1, 2022 | marketbeat.com Get Silverback Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address SBTX Media Mentions By Week SBTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SBTX News Sentiment▼0.000.56▲Average Medical News Sentiment SBTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SBTX Articles This Week▼00▲SBTX Articles Average Week Get Silverback Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CALT News ZYME News CMRX News CDMO News MBX News RVNC News CKPT News AVTE News TSVT News SLRN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SBTX) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silverback Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silverback Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.